Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Planta Med. 2010 Jul 19;77(2):188–195. doi: 10.1055/s-0030-1250145

Quorum Sensing Inhibitors for Staphylococcus aureus from Italian Medicinal Plants

Cassandra L Quave 1, Lisa RW Plano 2, Bradley C Bennett 1
PMCID: PMC3022964  NIHMSID: NIHMS238604  PMID: 20645243

Abstract

Morbidity and mortality estimates due to methicillin-resistant Staphylococcus aureus (MRSA) infections continue to rise. Therapeutic options are limited by antibiotic resistance. Anti-pathogenic compounds, which inhibit quorum sensing (QS) pathways, may be a useful alternative to antibiotics. Staphylococcal QS is encoded by the agr locus and is responsible for the production of δ-hemolysin. Quantification of δ-hemolysin found in culture supernatants permits the analysis of agr activity at the translational, rather than transcriptional, level. We employed RP-HPLC techniques to investigate the anti-QS activity of 168 extracts from 104 Italian plants through quantification of δ-hemolysin. Extracts from three medicinal plants (Ballota nigra, Castanea sativa, and Sambucus ebulus) exhibited a dose-dependent response in the production of δ-hemolysin, indicating strong anti-QS activity in a pathogenic MRSA isolate.

Keywords: quorum sensing, MRSA, medicinal plants, δ-toxin, δ-hemolysin, agr

Introduction

Emerging infections due to methicillin resistant Staphylococcus aureus (MRSA) pose a significant threat to hospital patients as the rates of nosocomial infection steadily rise [1]. Moreover, healthcare-associated MRSA (HA-MRSA) are often multidrug-resistant (MDR) and therapeutic options are rapidly becoming more limited as new resistant phenotypes surface. One approach to drug discovery for the treatment of MRSA is through natural products research. Most research on natural botanic products activity for MRSA is focused on growth inhibition, while some have focused on inhibition of the MDR mechanisms, such as efflux pumps [25]. No studies on the agr-inhibiting or quorum sensing inhibiting (QSI) activity of natural botanic products on MRSA have been conducted thus far. Inhibition of staphylococcal QS pathways could potentially limit the degree of pathogenicity posed by some MRSA strains by blocking the production of certain virulence factors. Moreover, the inhibition of staphylococcal pathogenesis could be accomplished without growth inhibition, thus potentially avoiding selective pressures for drug-resistance.

The staphylococcal QS system is a cell-density-dependent mechanism for controlling protein expression, including the production of staphylococcal virulence factors such as the α-, β, and δ-hemolysins. It is encoded by the agr locus, which is a quorum-sensing gene cluster of five genes (hld, agrA, agrB, agrC and agrD) [6].

Staphylococcal δ-hemolysin, or δ-toxin, is a translational protein product of RNAIII. It is a 26-aminoacid polypeptide with surfactant-like properties [7]. Translation of hld, the gene for δ-hemolysin, occurs about one hour after transcription of RNAIII. There are two forms of δ-toxin that can be found in the culture supernatant: formylated (with an N-terminal methionine) and deformylated. These forms are represented by two distinct peaks in the RP-HPLC chromatogram (Figure 1). δ-Toxin accumulates in the culture medium in both forms, and is approximately 90% formylated and 10% deformylated. This ratio is due to the arrest of deformylated δ-toxin production during the post-exponential growth phase, whereas formylated δ-toxin continues to accumulate. Sommerville et al. [8] suggest that this change may be linked to iron availability in the culture medium.

Fig. 1S.

Fig. 1S

Mass spectroscopic analysis of HPLC fractions containing derformylated and formylated δ-toxin. Peaks matching the spectrogram presented in the study by Somerville et al. [8] are highlighted. (a) Absorbance at 280nm of NRS385 (PFT USA500) supernatant fractionated by HPLC. (b) Mass spectrogram of peak 1, deformylated δ-toxin (molecular mass 2979.2 Da). (c) Mass spectrogram of peak 2, formylated δ-toxin (molecular mass of 3007.4 Da).

Quantification of δ-toxin produced by S. aureus and found in the culture supernatants allows for the analysis of agr activity at the translational, rather than transcriptional, level. The identification of agr-inhibiting drugs, or staphylococcal QS-inhibitors, has been proposed by several research groups as a potential anti-staphylococcal therapy [913]. In 2000, Otto and Götz [7] provided a fast method for δ-toxin quantification using RP-HPLC techniques for the analysis of staphylococcal culture filtrates. We apply this method for the first time as a screening tool for identifying plant extracts with QSI activity for a strain of HA-MRSA known as pulsed-field type (PFT) USA500.

USA500 isolates are SCCmecIV and MLST ST8. They are highly multidrug-resistant and tend to be associated with nosocomial transmission [14, 15]. USA500 is associated with the production of many virulence factors, including enterotoxins A and B, as well as δ-hemolysin, among others. There is a critical need for novel therapeutic options in the treatment of highly virulent, MDR staphylococcal infection, such as those caused by USA500.

We quantify the amount of δ-hemolysin found in the supernatant of MRSA cultures treated with plant extracts as a means of measuring the impact of plant products on the staphylococcal quorum sensing (QS) system. We examine 168 crude extracts made from 104 Italian plants, representing 44 plant families.

Materials and Methods

Plant material and extraction

Ethnobotanical surveys of plants used in the traditional pharmacopoeia of the Vulture-Alto Bradano region of Basilicata, southern Italy were conducted and results are described in previous works [1619]. Bulk and voucher specimens were collected and identified in 2006 by C. Quave. Voucher specimens of plants were deposited at the Herbarium Lucanum (HLUC) in Potenza, Italy and Fairchild Tropical Botanic Gardens (FTG) in Miami, FL, USA.

Dry plant materials were ground into a fine powder using a homogenizer. Ethanolic extracts of all plant samples were made by soaking in 95% denatured EtOH using a ratio of 1g (plant material):10 mL (EtOH) for 72 h. Flasks were agitated daily. Water extracts were made by boiling 1g (plant material): 50 mL (dH2O) for 30 minutes. Extracts were vacuum filtered and rotary-evaporated, then frozen and lyophilized. Stock concentrations of 10 mg/mL of dry extract in the excipient (DMSO or dH2O) were prepared, sterile filtered (0.2 μm) and stored in the dark at 4°C. The excipient (DMSO or dH2O) made up less than 5.1% of the final test solution for MIC assays and less than 2.5% for δ-toxin assays.

Bacteria and culture conditions

HA-MRSA PFT USA500 (NRS385) was obtained from the Network on Antimicrobial Resistance in Staphylococcus aureus (NARSA) repository [14]. Bacteria were grown on Tryptic Soy agar plates for 18 h at 37°C. A 1:20 dilution of a standardized inoculum (0.5 McFarland Standard) was used to create final inoculum densities of 5–8 × 105 CFU/mL from overnight cultures using the direct suspension method [20] for MIC and δ-toxin assays. Inoculum densities were confirmed by taking colony counts using the spread plate method at the time of inoculation.

Determination of minimum inhibitory concentrations (MICs)

MICs were determined by the microtiter broth method [21] in sterile flat-bottom 96-well polystyrene plates. We used serial dilution techniques to determine the MIC50 and MIC90 of extracts at concentrations of 8–512 μg/mL after 18 h growth. We included negative controls (cells + TSB), positive controls (cells + TSB + antibiotics − vancomycin, ampicillin, and trimethroprim-sulfamethoxazole), vehicle controls (cells + TSB + DMSO), and media controls (TSB). All tests were performed in triplicate. Optical density readings were taken using a KC4 microplate reader at 600 nm at 0 and 18 hours post-inoculation. Results are reported as the MIC for growth at 18 hours post-inoculation. To account for the effect of extract color on the OD600nm reading, a formula for calculating percent inhibition was used. The mean % inhibition of replicate tests was used to determine the final MIC values.

%inhibition=(1(ODt18ODt0ODgc18ODgc0))×100

ODt18 = optical density (600 nm) of the test well at 18 hours post-inoculation

ODt0 = optical density (600 nm) of the test well at 0 hours post-inoculation

ODgc18 = optical density (600 nm) of the growth control well at 18 hours post-inoculation

ODgc0 = optical density (600 nm) of the growth control well at 0 hours post-inoculation

Quantification of δ-toxin production

Polystyrene 24-well culture plates were prepared with a total volume of 1 mL per well of TSB, an initial sub-MIC test concentration of 64 μg of extract suspended in DMSO (<1% DMSO in total well volume) and bacteria. Extracts demonstrating significant activity, as exhibited by lower δ-toxin levels, were also investigated at a range of test concentrations from 8–256 μg/mL. Controls for media, growth, and growth in the carrier solvent (DMSO) were also performed. Liquid test cultures were grown for 15 hours at 37°C and aerated by shaking at 150 rpm. All tests were performed in triplicate.

Aliquots of bacteria (2 mL) were centrifuged for 5 min at 14,000 × g with a microcentrifuge. Supernatants were removed and stored at −20 °C until HPLC analysis. The concentration of δ-toxin was measured by RP-HPLC with a 1-mL Resource PHE column (GE Healthcare, Uppsala, Sweden) as previously described [7], except that 200 μL of supernatant (as opposed to 500 μL) was injected onto the column using a Thermo Spectra-System HPLC apparatus, equipped with a Diode Array Detector and autosampler (Thermo Electron Corporation, San Jose, CA) and ChromQuest 4.1 software.

δ-Hemolysin elutes at a retention time of about 6.4 minutes (deformylated) and 6.8 minutes (formylated) after sample injection as two distinct peaks. Integration of the δ-toxin peak area was performed at 280 nm. We confirmed the identity of δ-toxin peaks by peak fractionation and LC-mass spectrometry (Fig. 1S) using a Thermo Finnigan Deca XP max ion trap mass spectrometer and surveyor LC with autosampler and diode array detector (Thermo Electron Corporation, San Jose, CA) using conditions previously described [8]. The peak areas were calculated using ChromQuest software and the mean percent inhibition of δ-toxin production for the replicate tests was calculated in relation to the mean peak area of the excipient (DMSO) growth controls.

Statistical analysis

All experiments were carried out in triplicate. Data were analyzed using Microsoft Excel and SPLUS software. Differences between the means of the experimental and control groups were evaluated with two-sample t-tests using SPLUS software.

Results

There was a broad low level response of δ-toxin inhibition to the screening test concentration of 64 μg/mL. QSI activity was apparent in 90% of the extracts tested (Table 1). No QSI activity was apparent in aqueous extracts. This suggests that the active QSI components are predominantly nonpolar in nature. Extracts were not effective at inhibiting growth of this multidrug-resistant strain of HA-MRSA (USA500/NRS385). Only 6% of extracts demonstrated a MIC50 at concentrations of 256–512 μg/mL. None demonstrated a MIC90 at concentrations ≤ 512 μg/mL.

Table 1.

Inhibition of δ-toxin and minimal inhibitory concentrations of plant extracts against MRSA (strain I.D. NRS385/PFT USA500).

Family Botanic Name Voucher ID Plant Part Ethno-botanical Use* Extract Solvent Percent Inhibition of δ-toxin Production** MIC50***
Adoxaceae Sambucus ebulus L. CQ-168 inflorescence N EtOH 45 -
leaves S EtOH 48 -
stems N EtOH 28 -
Sambucus nigra L. CQ-151 woody parts R EtOH 29 -
leaves S EtOH 36 -
dH2O - -
inflorescence S; R EtOH 38 -
dH2O - -
infructescence F EtOH 34 -
Alliaceae Allium cepa L. CQ-206 leaves; bulbs; roots S; M; F EtOH 22 -
Apiaceae Daucus carota L. CQ-215 leaves; stems N EtOH 2 -
inflorescence; infructescence N EtOH 39 -
Foeniculum vulgare ssp. piperitum (Ucria) Coutinho CQ-192 leaves; stems M; F EtOH - -
Foeniculum vulgare ssp. vulgare Mill. CQ-196 leaves; stems M EtOH 8 -
Tordylium apulum L. CQ-101 flowers; leaves; roots; stems N EtOH 25 -
Apocynaceae Vinca major L. CQ-117 flowers; leaves; roots; stems M EtOH 26 -
Aracaeae Arum italicum Mill. CQ-175 stems N EtOH 28 -
fruits N EtOH 15 -
stalks N EtOH 2 -
leaves S EtOH 22 -
Asphodelaceae Asphodelus microcarpus_Salzm. & Viv. CQ-109 inflorescence N EtOH 19 -
leaves N EtOH 17 -
Asteraceae Achillea ageratum L. CQ-219 leaves; stems; flowers M EtOH 66 512
Achillea millefolium L. CQ-176 inflorescence M EtOH 41 -
leaves; stems M EtOH 23 -
leaves; stems; flowers M EtOH 38 -
Anacyclus tomentosus DC. CQ-167 leaves; stems; flowers N EtOH 36 -
Cichorium intybus L. CQ-106 basal leaves; roots F EtOH 23 -
dH2O - -
leaves; stems; flowers F EtOH 8 -
Matricaria recutita L. CQ-118 flowers; leaves; roots; stems S; M EtOH 29 512
dH2O - -
Scolymus hispanicus L. CQ-199 leaves; stems; flowers N EtOH 23 -
Tussilago farfara L. CQ-202 leaves; stems; roots S EtOH 16 -
Urospermum dalechampii (L.) Scop. CQ-134 flowers; leaves; roots; stems N EtOH 14 -
Boraginaceae Anchusa officinalis L. CQ-128 leaves; stems; flowers N EtOH 34 -
Borago officinalis L. CQ-100 flowers; leaves; roots; stems M EtOH 54 -
dH2O - -
Cerinthe major L. CQ-110 flowers; leaves; roots; stems N EtOH 48 -
Echium italicum L. CQ-162 leaves; stems; flowers N EtOH 32 -
Brassicaceae Brassica rapa subsp. rapa CQ-104 flowers; leaves; roots; stems F EtOH 27 -
Cardaria draba (L.) Desv. CQ-140 flowers; leaves; roots; stems N EtOH 12 -
Eruca sativa Mill. CQ-102 flowers; leaves; roots; stems N EtOH 13 -
Sisymbrium officinale (L.) Scop. CQ-131 flowers; leaves; roots; stems N EtOH 20 -
Caprifoliaceae Lonicera alpigena L. CQ-213 woody parts N EtOH 28 -
leaves N EtOH 25 -
Caryophyllaceae Saponaria officinalis L. CQ-210 leaves; stems; flowers N EtOH 4 -
Silene alba (Mill.) E.H.L. Krause CQ-123 leaves; stems; flowers N EtOH 43 -
Silene nutans L. CQ-125 leaves; stems; flowers N EtOH 43 -
Cucurbitaceae Ecballium elaterium (L.) A. Richard CQ-169 leaves; stems; flowers S EtOH 21 -
Dennstaedtiaceae Pteridium aquilinium (L.) Kuhn CQ-211 leaves N EtOH - -
stems N EtOH 24 -
Dipsacaceae Dipsacus fullonum L. CQ-201 leaves; stems N EtOH 28 -
flowers N EtOH 28 -
Knautia arvensis Coult. CQ-190 leaves; stems; flowers N EtOH 48 -
Knautia lucana Lacaita & Szabo CQ-166 leaves; stems; flowers N EtOH 6 -
Equisetaceae Equisetum arvense L. CQ-226 stems; leaves N EtOH 22 -
Fabaceae Acacia dealbata Link CQ-115 inflorescence O EtOH 56 -
stems O EtOH 38 -
leaves; stems O EtOH 21 -
Anthyllis vulneraria L. CQ-147 leaves; stems; flowers N EtOH 28 -
Astragalus monspessulanus L. CQ-112 leaves; stems; flowers; roots N EtOH 36 -
Coronilla emerus L. CQ-137 leaves; flowers N EtOH 33 -
woody stems N EtOH 14 -
Melilotus alba_Medik. CQ-193 leaves; stems; flowers N EtOH 43 -
Robinia pseudoacacia L. CQ-155 woody parts N EtOH 32 -
leaves N EtOH - -
inflorescence N EtOH 21 -
Spartium junceum L. CQ-144 leaves; stems; flowers A EtOH 22 -
Trifolium repens L. CQ-138 leaves; stems; flowers; roots N EtOH 4 -
Vicia craca L. CQ-149 leaves; stems; flowers; roots N EtOH 19 -
Vicia faba L. CQ-103 leaves; stems; flowers; roots F EtOH 14 -
Vicia sativa subsp. angustifolio CQ-124 leaves; stems; flowers N EtOH 22 512
Vicia sativa subsp. sativa CQ-119 leaves; stems; flowers N EtOH 29 -
Wisteria sinensis (Sims) Sweet CQ-126 inflorescence O EtOH 36 -
stems O EtOH 39 -
leaves O EtOH 41 -
Fagaceae Castanea sativa Mill. CQ-191 inflorescence N EtOH 20 -
leaves N EtOH 70 512
woody parts A EtOH 32 512
Quercus cerris L. CQ-228 leaves N EtOH 27 -
stems; fruits N EtOH 37 -
Gentianaceae Centaurium pulchellum (Sw.) Druce CQ-217 leaves; stems; flowers; roots N EtOH 21 -
Geraniaceae Erodium ciconium (L.) L’Hér. CQ-142 leaves; stems; flowers; roots N EtOH 34 -
Erodium malacoides (L.) L’Hér. ex Aiton CQ-121 leaves; stems; flowers N EtOH 7 512
Geranium columbinum L. CQ-129 leaves; stems; flowers N EtOH - -
Hyacinthaceae Leopoldia comosa (L.) Parl. CQ-105 bulbs M; F EtOH 21 -
dH2O - -
leaves; inflorescence N EtOH 31 -
Hypericaceae Hypericum perforatum L. CQ-183 leaves; stems; flowers S EtOH 36 -
Juglandaceae Juglans regia L. CQ-181 immature fruits S; C EtOH - -
leaves R EtOH 39 -
woody parts N EtOH 17 -
Juncaceae Juncus articulatus L. CQ-216 leaves; fruits N EtOH 32 -
Lamiaceae Ballota nigra L. CQ-160 stems S; M EtOH 76 -
roots N EtOH 37 -
leaves S; M EtOH 47 -
leaves; stems; flowers S; M EtOH 47 -
dH2O - -
Clinopodium vulgare L. CQ-182 leaves; stems; flowers N EtOH 40 -
Marrubium vulgare L. CQ-170 leaves; stems; flowers S; M EtOH 40 -
dH2O 6 -
roots N EtOH 40 -
Mentha pulegium L. CQ-200 leaves; stems; flowers; roots F EtOH 36 -
Mentha spicata L. CQ-224 leaves; stems; flowers F EtOH 28 -
Origanum heracleoticum L. CQ-207 leaves; stems; flowers F EtOH 30 -
Phlomis herba-venti L. CQ-168 leaves; stems; flowers N EtOH 16 -
Rosmarinus officinalis L. CQ-113 leaves; stems; flowers F; S EtOH 58 256
Salvia pratensis L. CQ-165 leaves; stems N EtOH 23 -
inflorescence N EtOH 58 -
Salvia virgata Jacq. CQ-127 leaves; stems; flowers N EtOH 42 256
Stachys tymphaea Hausskn. CQ-189 leaves; stems; flowers N EtOH 41 -
Liliaceae Lilium candidum L. CQ-174 leaves; stems N EtOH 37 -
inflorescence N EtOH 30 -
Malvaceae Alcea rosea L. CQ-205 leaves; stems; flowers; roots O EtOH 18 -
Malva sylvestris L. CQ-156 stems S; M EtOH 22 -
dH2O - -
flowers S; M EtOH 53 -
leaves S; M EtOH 34 -
dH2O - -
Moraceae Ficus carica L. CQ-173 leaves N EtOH 24 -
woody parts N EtOH 21 -
immature fruits S; F EtOH 41 -
Myrsinaceae Cyclamen hederifolium Aiton CQ-186 tubers M EtOH 10 -
Nyctaginaceae Mirabilis jalapa L. CQ-222 leaves; flowers; fruits N EtOH 16 -
Oleaceae Olea europaea L. CQ-197 leaves N EtOH 40 -
woody parts A EtOH 24 -
Orchidaceae Aceras anthropophora R. Br. CQ-153 leaves; stems; flowers; roots N EtOH 51 -
Orchis italica Poir. CQ-133 inflorescence; leaves; stems N EtOH 49 -
Orchis purpurea Huds. CQ-132 inflorescence; leaves; stems N EtOH 57 -
Papaveraceae Fumaria officinalis L. CQ-107 leaves; stems; flowers; roots N EtOH 44 -
Papaver rhoeas subsp. rhoeas CQ-145 leaves; stems; flowers; roots F EtOH 25 -
Papaver somniferum L. CQ-178 leaves; stems; flowers; roots M; R EtOH 36 -
Plantaginaceae Digitalis ferruginea L. CQ-227 leaves; stems; flowers N EtOH 32 -
Linaria vulgaris Hill CQ-223 leaves; stems; flowers; roots N EtOH 25 -
Plantago major L. CQ-225 leaves; stems; flowers; roots S; M EtOH 12 -
Poaceae Agropyron repens (L.) P. Beauv. CQ-208 leaves; stems; roots M EtOH 19 -
Arundo donax L. CQ-146 stem internodes A; R EtOH 22 -
stem nodes S EtOH 35 -
dH2O - -
leaves; stems A; R EtOH 10 -
Polygonaceae Rumex crispus L. CQ-171 leaves; stems; fruits S EtOH 25 -
Pottiaceae Syntrichia ruralis (Hedw.) Web. & Mohr CQ-229 whole plant N EtOH 45 -
Ranunculaceae Delphinium fissum Waldst. & Kit. CQ-187 leaves; stems; flowers; fruits N EtOH 29 -
Ranunculus acris L. CQ-135 leaves; stems; flowers N EtOH 34 -
Rosaceae Crataegus monogyna Jacq. CQ-116 leaves; stems; flowers M EtOH 57 -
Prunus spinosa L. CQ-163 woody parts; leaves M EtOH 33 -
fruits N EtOH 29 512
Rosa canina var. canina CQ-152 fruits N EtOH 16 -
woody parts N EtOH 44 -
leaves; stems N EtOH 14 512
Rubus ulmifolius Schott CQ-164 leaves; stems; flowers S EtOH 10 -
leaves S EtOH 17 -
roots M EtOH 21 -
woody stems N EtOH 16 512
Rubiaceae Galium verum L. CQ-177 leaves; stems; flowers N EtOH 27 -
Scrophulariaceae Verbascum sinuatum L. CQ-218 leaves; stems; flowers N EtOH 34 -
Verbascum thapsus L. CQ-172 stems M EtOH 31 -
leaves M EtOH 40 -
inflorescence M EtOH 38 -
Ulmaceae Ulmus minor L. CQ-195 leaves N EtOH 23 -
woody parts M EtOH - -
Urticaceae Parietaria diffusa Mert. & Koch CQ-212 leaves; stems; fruits; roots M EtOH 19 -
Urtica dioica L. CQ-179 leaves; stems; flowers S; M; F EtOH 36 -
Valerianaceae Centranthus ruber (L.) DC. CQ-143 leaves; stems; inflorescence M EtOH 31 -
Vitaceae Vitis vinifera var. aglianico CQ-209 wine S; F - -
stems N EtOH - -
fruits F EtOH 21 -
leaves N EtOH 22 -
*

Ethnobotanical use of specific plant part(s) in the study region: S = medicinal application to skin; M = medicinal application not involving the skin; C = cosmetic applications; A = agricultural tool; O = ornamental; R = ritual or spiritual use; F = food; N = no reported use.

**

percent inhibition for δ-toxin based on an initial screening concentration of 64 μg/mL for MRSA PFT USA500.

***

MIC values are reported as μg/mL for MRSA PFT USA500.

“-”signifies no inhibitory activity

Three ethanolic extracts demonstrated significant δ-toxin inhibition, and come from the following plant species: Ballota nigra, Castanea sativa, and Sambucus ebulus. Interestingly, each of these species is applied in south Italian folk remedies for skin and soft tissue infection [19]. The HPLC chromatograms and graphs of the percent inhibition of δ-toxin (by measure of peak area) for these species demonstrate a strong dose-dependent response (Fig. 2S and 3).

Fig. 2S.

Fig. 2S

HPLC chromatogram of δ-toxin after treatment with different concentrations of plant extract. (a) EtOH extract of Ballota nigra stems. (b) EtOH extract of Castanea sativa leaves. (c) EtOH extract of Sambucus ebulus leaves.

Fig. 3.

Fig. 3

Percent inhibition of δ-toxin peak area after treatment with extracts of Ballota nigra, Castanea sativa and Sambucus ebulus.

Discussion

Quantification of δ-hemolysin in the supernatant of staphylococcal cultures can be used as a measure of agr system, or QS, activity [79]. The agr system controls approximately 150 genes and is critical to S. aureus virulence [22]. While the staphylococcal QS system is a useful target for the discovery and development of new anti-pathogenic drugs, the dynamic nature of the agr system must not be overlooked. A better understanding of the effect that agr manipulation can have on the development of infection in vivo is necessary. For example, inhibiting agr activity during certain times in the infection process can lead to deleterious effects, such as increased biofilm formation [23].

Based on analyses of δ-hemolysin production, we have offered the first reports of plant extracts interfering with QS pathways in MRSA. These results indicate that some degree of QSI activity is evident in 90% of the 168 Italian plant extracts screened, including those extracts with no growth inhibitory activity.

The validity of plant-based therapies for infection that do not exhibit activity in the standard in vitro bacteriostatic or bactericidal assays is oftentimes questioned. These data, however, support the idea that other mechanisms of action may be in play, which do not necessarily impact bacterial growth, but virulence mechanisms, instead. These data give validity to the use of south Italian folk remedies incorporating Ballota nigra, Castanea sativa, and Sambucus ebulus for the treatment of skin and soft tissue infection. Further investigation, including the fractionation and isolation of active components from these three species is recommended.

Acknowledgments

This work was funded by NIH, NCCAM (Grant # F31AT004288, PI: C.L. Quave). The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Center for Complementary and Alternative Medicine or the National Institutes of Health. Additional support for the project was provided by Botany in Action (C. L. Quave), and Anne Chatham Fellowship in Medicinal Botany (C.L. Quave). We thank Dr. Carmine Colacino (Universitá della Basilicata, Potenza, Italy) and Dr. Andrea Pieroni (University of Gastronomic Sciences, Pollenzo/Bra, Italy) for assisting in the taxonomic identification of plants collected. Special thanks to Dr. Michael Otto (National Institutes of Health/National Institute of Allergy and Infectious Diseases, Bethesda, USA) for assisting in the setup of the experiment. We also thank Dr. Horacio Preistap and Myron Georgiadis (Florida International University, Miami, USA) for technical support in the use of HPLC and MS equipment, respectively.

References

  • 1.Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003. Clin Infect Dis. 2006;43:387–388. doi: 10.1086/499367. [DOI] [PubMed] [Google Scholar]
  • 2.Gibbons S, Oluwatuyi M, Kaatz GW. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother. 2003;51:13–17. doi: 10.1093/jac/dkg044. [DOI] [PubMed] [Google Scholar]
  • 3.Gibbons S, Oluwatuyi M, Veitch NC, Gray AI. Bacterial resistance modifying agents from Lycopus europaeus. Phytochemistry. 2003;62:83–87. doi: 10.1016/s0031-9422(02)00446-6. [DOI] [PubMed] [Google Scholar]
  • 4.Gibbons S, Udo EE. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Phytother Res. 2000;14:139–140. doi: 10.1002/(sici)1099-1573(200003)14:2<139::aid-ptr608>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  • 5.Pereda-Miranda R, Kaatz GW, Gibbons S. Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistamce in Staphylococcus aureus. J Nat Prod. 2006;69:406–409. doi: 10.1021/np050227d. [DOI] [PubMed] [Google Scholar]
  • 6.Sakoulas G, Eliopoulos GM, Moellering RC, Wennersten C, Venkataraman L, Novick RP, Gold HS. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to Vancomycin. Antimicrob Agents Chemother. 2002;46:1492–1502. doi: 10.1128/AAC.46.5.1492-1502.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Otto M, Götz F. Analysis of quorum sensing activity in staphylococci by RP-HPLC of staphylococcal delta-toxin. BioTechniques. 2000;28:1088–1096. doi: 10.2144/00286bm07. [DOI] [PubMed] [Google Scholar]
  • 8.Somerville GA, Cockayne A, Durr M, Peschel A, Otto M, Musser JM. Synthesis and deformylation of Staphylococcus aureus δ-Toxin are linked to Tricarboxylic Acid Cycle Activity. J Bacteriol. 2003;185:6686–6694. doi: 10.1128/JB.185.22.6686-6694.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Otto M. Quorum-sensing control in Staphylococci - a target for antimicrobial drug therapy? FEMS Microbiol Lett. 2004;241:135–141. doi: 10.1016/j.femsle.2004.11.016. [DOI] [PubMed] [Google Scholar]
  • 10.Dell’Acqua G, Giacometti A, Cirioni O, Ghiselli R, Saba V, Scalise G, Gov Y, Balaban N. Suppression of drug-resistant staphylococcal infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. J Infect Dis. 2004;190:318–320. doi: 10.1086/386546. [DOI] [PubMed] [Google Scholar]
  • 11.Balaban N, Goldkorn T, Nhan RT, Dang LB, Scott S, Ridgley RM, Rasooly A, Wright SC, Carlson JR. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science. 1998;280:438–440. doi: 10.1126/science.280.5362.438. [DOI] [PubMed] [Google Scholar]
  • 12.Otto M, Submuth R, Vuong C, Jung G, Gotz F. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Lett. 1999;450:257–262. doi: 10.1016/s0014-5793(99)00514-1. [DOI] [PubMed] [Google Scholar]
  • 13.Mayville P, Ji G, Beavis R, Yang H, Goger M, Novick RP, Muir TW. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci USA. 1999;96:1218–1223. doi: 10.1073/pnas.96.4.1218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.NARSA. The Network on Antimicrobial Resistance in Staphylococcus aureus. [Accessed March 20, 2010]; Available at http://www.narsa.net.
  • 15.McDougal LK, Steward CD, Killgore GE, Chaitram J, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: Establishing a national database. J Clin Microbiol. 2003;41:5113–5120. doi: 10.1128/JCM.41.11.5113-5120.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pieroni A, Nebel S, Quave CL, Munz H, Heinrich M. Ethnopharmacology of liakra: traditional weedy vegetables of the Arberëshë of the Vulture area in southern Italy. J Ethnopharmacol. 2002;81:165–185. doi: 10.1016/s0378-8741(02)00052-1. [DOI] [PubMed] [Google Scholar]
  • 17.Pieroni A, Quave CL, Nebel S, Heinrich M. Ethnopharmacy of the ethnic Albanians (Arbëreshë) of northern Basilicata, Italy. Fitoterapia. 2002;73:217–241. doi: 10.1016/s0367-326x(02)00063-1. [DOI] [PubMed] [Google Scholar]
  • 18.Pieroni A, Quave CL. Traditional pharmacopoeias and medicines among Albanians and Italians in southern Italy: A comparison. J Ethnopharmacol. 2005;101:258–270. doi: 10.1016/j.jep.2005.04.028. [DOI] [PubMed] [Google Scholar]
  • 19.Quave CL, Pieroni A, Bennett BC. Dermatological remedies in the traditional pharmacopoeia of Vulture-Alto Bradano, inland southern Italy. J Ethnobio Ethnomed. 2008;4:5. doi: 10.1186/1746-4269-4-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Isenberg HD. Clinical Microbiology Procedures Handbook. 2. Washington, D.C: ASM Press; 2004. [Google Scholar]
  • 21.Amsterdam D. Susceptibility testing of antimicrobials in liquid media. In: Loman V, editor. Antibiotics in laboratory medicine. Baltimore, MD: Williams and Wilkins; 1996. pp. 52–111. [Google Scholar]
  • 22.Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J Bacteriol. 2001;183:7341–7353. doi: 10.1128/JB.183.24.7341-7353.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Harraghy N, Kerdudou S, Herrmann M. Quorum-sensing systems in staphylococci as therapeutic targets. Anal Bioanal Chem. 2007;387:437–444. doi: 10.1007/s00216-006-0860-0. [DOI] [PubMed] [Google Scholar]

RESOURCES